Covid-19 vaccine makers need to focus on broadening the protection of their annual boosters down the line to optimize uptake of future shots, the FDA’s vaccine chief said Tuesday.
“We need to get to something that has a broader breadth of protection, probably first and foremost, and a longer duration of action,” Peter Marks, director of the Center for Biologics Evaluation and Research at the Food and Drug Administration, said at the World Vaccine Congress. “Breadth is probably the most important thing because I think people will get an annual vaccine—if they think it’s going to protect them broadly.”
The ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.